Kymera Therapeutics KYMR Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Kymera Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's quick ratio?
- Kymera Therapeutics (KYMR) reported quick ratio of 10.8× in Q1 2026.
- How has Kymera Therapeutics's quick ratio changed year-over-year?
- Kymera Therapeutics's quick ratio increased by 27.3% year-over-year, from 8.5× to 10.8×.
- What is the long-term trend for Kymera Therapeutics's quick ratio?
- Over 5 years (2020 to 2025), Kymera Therapeutics's quick ratio has grown at a 30.8% compound annual growth rate (CAGR), from 2.7× to 10.5×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.